The Global Mental Health Screening Market size is expected to reach $2.4 billion by 2031, rising at a market growth of 12.5% CAGR during the forecast period.
Sleep disorders can have a significant impact on mental health, exacerbating symptoms of depression, anxiety, and other mental health disorders. Thus, the sleep disorder segment acquired 14.7% revenue share in the market 2023. Screening for sleep disorders can help identify and address these issues, leading to improved mental health outcomes. Moreover, advances in screening tools and diagnostic criteria have made it easier to detect sleep disorders accurately, leading to increased use of screening tools in clinical settings.
Collaboration between researchers, healthcare providers, and technology companies also drives innovation in mental health screening. By working together, these stakeholders can leverage their expertise to develop and implement new screening tools and technologies.
Additionally, Mental disorders constitute the primary cause of years lived with disability (YLDs) on a global scale, affecting one in every six YLDs. Schizophrenia, which affects an estimated 1 in 200 adults, is a significant concern because it is the most debilitating of all health conditions in its acute stages. Hence, the escalating incidence of mental health disorders on a global scale has substantially bolstered the need for screening instruments and services about mental health.
However, many regions have a shortage of professionals with the necessary expertise to administer and interpret its tools. This shortage is particularly acute in areas with high demand for mental health services, such as rural or underserved communities. Hence, these factors may hamper the growth of the market.
However, the pandemic also presented challenges for the market. The economic impact of the pandemic led to financial strain for many individuals, making it difficult for them to afford mental health screening services. Additionally, the increased demand for mental health services during the pandemic placed a strain on mental health providers, leading to longer wait times for screening and treatment. Therefore, the pandemic had a negative impact on the market.
The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The below illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Acquisitions, and Partnerships & Collaborations.
Sleep disorders can have a significant impact on mental health, exacerbating symptoms of depression, anxiety, and other mental health disorders. Thus, the sleep disorder segment acquired 14.7% revenue share in the market 2023. Screening for sleep disorders can help identify and address these issues, leading to improved mental health outcomes. Moreover, advances in screening tools and diagnostic criteria have made it easier to detect sleep disorders accurately, leading to increased use of screening tools in clinical settings.
Collaboration between researchers, healthcare providers, and technology companies also drives innovation in mental health screening. By working together, these stakeholders can leverage their expertise to develop and implement new screening tools and technologies.
Additionally, Mental disorders constitute the primary cause of years lived with disability (YLDs) on a global scale, affecting one in every six YLDs. Schizophrenia, which affects an estimated 1 in 200 adults, is a significant concern because it is the most debilitating of all health conditions in its acute stages. Hence, the escalating incidence of mental health disorders on a global scale has substantially bolstered the need for screening instruments and services about mental health.
However, many regions have a shortage of professionals with the necessary expertise to administer and interpret its tools. This shortage is particularly acute in areas with high demand for mental health services, such as rural or underserved communities. Hence, these factors may hamper the growth of the market.
However, the pandemic also presented challenges for the market. The economic impact of the pandemic led to financial strain for many individuals, making it difficult for them to afford mental health screening services. Additionally, the increased demand for mental health services during the pandemic placed a strain on mental health providers, leading to longer wait times for screening and treatment. Therefore, the pandemic had a negative impact on the market.
The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The below illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Acquisitions, and Partnerships & Collaborations.
Age Group Outlook
On the basis of age group, the market is segmented into children & adolescents (age 0-18 years), adults (age 19-64 years), and seniors (age 65 and above). The adults (age 19-64) segment witnessed 55.4% revenue share in the market in 2023.Setting Outlook
By setting, the mental health screening market is divided into clinical settings, educational institutions, workplace/corporate programs, online platforms, and others. The online platforms segment acquired 22.8% revenue share in the mental health screening market in 2023.Technology Outlook
Based on technology, the market is segmented into self-screening mHealth apps, telehealth & virtual care solutions, continuous monitoring wearable devices, AI-based screening tools, and others. The continuous monitoring wearable devices segment witnessed 19.5% revenue share in the mental health screening market in 2023.Screening Method Outlook
By screening method, the market is divided into self-reported questionnaires & surveys, clinical interviews, observation-based assessments, and biomarker testing. The clinical interviews segment procured a 30.9% growth rate in the market in 2023.
Application Outlook
On the basis of application, the market is classified into physiological disorders, psychiatric disorders, behavioral disorders, and cognitive disorders. The cognitive disorders segment recorded 12.7% growth rate in the market in 2023.Physiological Disorders Outlook
The physiological disorders segment is further segmented into depression & anxiety, eating disorder, post-traumatic stress disorder (PTSD), bipolar disorder, and others. The eating disorder segment garnered 15.6% revenue share in the market in 2023.Psychiatric Disorders Outlook
The psychiatric disorders segment is further divided into attention deficit hyperactivity disorder (ADHD), psychotic disorder, dissociative disorder, obsessive compulsive disorder, schizophrenia, and others. The attention deficit hyperactivity disorder (ADHD) segment procured 35.2% revenue share in the market in 2023.Cognitive Disorders Outlook
The cognitive disorders segment is divided into cognitive impairment, dementia, Alzheimer’s disease, and others. The cognitive impairment segment garnered a 31% growth rate in the market in 2023.Behavioral Disorders Outlook
The behavioral disorders segment is further segmented into self-harm, aggression, sleep disorder, social withdrawal, dissociative disorder, hyperactivity, and others. The self-harm segment procured 27.8% revenue share in the market in 2023.By Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Europe segment garnered 29.7% growth rate in the market in 2023.List of Key Companies Profiled
- Proem Heath, Inc.
- SonderMind, Inc
- ResMed, Inc.
- Headspace, Inc.
- Quartet Inc.
- Fitbit, Inc. (Google LLC)
- Sonde Health, Inc. (Puretech Health Plc)
- Koninklijke Philips N.V
- Apple, Inc
- Canary Speech, Inc
Market Report Segmentation
By Age Group- Adults (age 19-64 years)
- Children & Adolescents (age 0-18 years)
- Seniors (age 65 and above)
- Clinical Settings
- Educational Institutions & Others
- Workplace/Corporate Programs & Online Platforms
- Telehealth & Virtual Care Solutions
- Self-screening mHealth Apps
- AI-based Screening Tools
- Continuous Monitoring Wearable Devices & Others
- Self-reported Questionnaires & Surveys
- Clinical Interviews
- Observation-based Assessments
- Biomarker Testing
- Physiological Disorders
- Depression & Anxiety
- Eating Disorder
- Post-Traumatic Stress Disorder (PTSD)
- Bipolar Disorder
- Others
- Psychiatric Disorders
- Attention Deficit Hyperactivity Disorder (ADHD)
- Psychotic Disorder
- Dissociative Disorder
- Obsessive Compulsive Disorder
- Schizophrenia
- Others
- Cognitive Disorders
- Cognitive Impairment
- Dementia
- Alzheimer's Disease & Others
- Behavioral Disorders
- Self-Harm
- Aggression
- Sleep Disorder
- Social Withdrawal
- Dissociative Disorder
- Hyperactivity
- Others
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Global Mental Health Screening Market by Age Group
Chapter 6. Global Mental Health Screening Market by Setting
Chapter 7. Global Mental Health Screening Market by Technology
Chapter 8. Global Mental Health Screening Market by Screening Method
Chapter 9. Global Mental Health Screening Market by Application
Chapter 10. Global Mental Health Screening Market by Region
Companies Mentioned
- Proem Heath, Inc.
- SonderMind, Inc
- ResMed, Inc.
- Headspace, Inc.
- Quartet Inc.
- Fitbit, Inc. (Google LLC)
- Sonde Health, Inc. (Puretech Health Plc)
- Koninklijke Philips N.V
- Apple, Inc
- Canary Speech, Inc
Methodology
LOADING...
